Study start-up
Start with the right foundations.
Turn the study brief into a documented readiness plan for the protocol, institutions, approvals and people involved.
Planned · availability unverifiedDiscuss your studyMap the dependencies
Identify the sponsor, Nepal investigator, candidate sites, study functions and authority decisions. Distinguish documents that can be prepared in parallel from steps dependent on an approval or product permit. Record assumptions rather than treating an indicative schedule as an approval commitment.
Build a controlled start-up package
Keep a versioned checklist with a named owner and review status for each deliverable.
- Feasibility and site-selection evidence
- Investigator qualifications and institutional support
- Submission documents and participant materials
- Contracts, budgets and responsibility allocation
- Product, equipment and laboratory readiness
- Staff training and site-initiation records
Track review and authorization
Maintain the submitted versions, authority correspondence, responses and approval conditions. Ethics approval and product authorization are distinct, and institutional permissions must also be addressed. Verify registration and any permit requirements before the first participant is recruited. Check IRERP routing and NCTR registration through the official links in Resources.
Document the activation decision
Use a readiness review to verify that outstanding actions are resolved or formally accepted by the responsible parties. Confirm the approved protocol and consent versions, staff delegation, safety contacts, essential records and supply arrangements. Start-up coordination does not independently authorize a site to recruit.
Common questions
Clarify the scope.
How is the scope agreed?
Begin with the protocol and required deliverables, then confirm the team, responsibilities, dependencies and acceptance criteria in writing. Service availability must be confirmed before commitment.
Can approval, recruitment or delivery dates be guaranteed?
No. Authority decisions, site capacity and study circumstances determine the schedule. Planning should identify assumptions and dependencies rather than promise an outcome.
Sources and further reading
Additional Resource
- NHRC — National Ethical Guidelines for Health Research in Nepal (2022)
- Department of Drug Administration — Regulatory role
- WHO — Primary registries in the clinical trials registry network
- ICH — E6(R3) Good Clinical Practice, Principles and Annex 1 (2025)
- NHRC — Nepal Clinical Trials Registry project and IRERP migration notice
- WHO — Other registries, including Nepal
Related pages
A study-specific conversation
Let’s clarify what your study needs.
Start with a clear brief. Shape the right support around your study.


